ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT05204927

Public ClinicalTrials.gov record NCT05204927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T Versus Hormone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Study identification

NCT ID
NCT05204927
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Curium US LLC
Industry
Enrollment
439 participants

Conditions and interventions

Interventions

  • 177Lu-PSMA-I&T Drug
  • Abiraterone with Prednisone or Enzalutamide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 13, 2022
Primary completion
Aug 1, 2024
Completion
Jan 31, 2029
Last update posted
Jul 30, 2025

2022 – 2029

United States locations

U.S. sites
37
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Arizona Institute of Urology, PPLC Tucson Arizona 85704
Providence Medical Foundation Fullerton California 92835
Long Beach Memorial Center Long Beach California 90806
Hoag Memorial Hospital Presbyterian Newport Beach California 92663
San Francisco VA Health Care System San Francisco California 94121
University of California, San Francisco San Francisco California 94158
Providence Saint John's Health Center Santa Monica California 90404
GenesisCare USA Boca Raton Florida 33431
Biogenix Molecular LLC Miami Florida 33165
Orlando Health Cancer Institute Orlando Florida 32806
GenesisCare USA Plantation Florida 33324
Florida Urology Partners, LLP Tampa Florida 33607
Northwestern Memorial Hospital Chicago Illinois 60611
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201
John Hopkins Hospital Baltimore Maryland 21287
Kaiser Permanente Gaithersburg Medical Center Gaithersburg Maryland 20879
Henry Ford Hospital Detroit Michigan 48202
BAMF Health I PC Grand Rapids Michigan 49503
Michigan Institute of Urology Troy Michigan 48084
GenesisCare USA Troy Michigan 48098
M Health Fairview Ridges Cancer Clinic Burnsville Minnesota 55337
SSM Saint Louis University Hospital St Louis Missouri 63104
Center for Clinical Theranostics Research, Washington University St Louis Missouri 63110
Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha Nebraska 68130
XCancer Omaha / Urology Cancer Center Omaha Nebraska 68130
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08993
Icahn School of Medicine at Mount Sinai New York New York 10029
Columbia University Medical Center - Herbert Irving Pavilion New York New York 10032
SUNY Upstate Medical University Syracuse New York 13210
Central Ohio Urology Group Gahanna Ohio 43230
Hightower Clinical Oklahoma City Oklahoma 73102
OHSU - Center for health and healing Portland Oregon 97239
VA Portland Health Care System Portland Oregon 97239
MidLantic Urology Bala-Cynwyd Pennsylvania 19004
Houston Metro Urology Houston Texas 77027
Urology San Antonio San Antonio Texas 78229
Fred Hutchinson Cancer Center Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05204927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05204927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →